The role of cyclic nucleotides in the release of tissue-type plasminogen activator and von Willebrand factor

Thromb Haemost. 1993 Mar 1;69(3):259-61.

Abstract

The modulation of the induced acute release of tissue-type plasminogen activator (t-PA) and of von Willebrand factor (vWF) by compounds affecting cyclic nucleotide levels was studied, using an isolated rat hindleg perfusion system. Platelet-activating factor (PAF; 5 nM) or bradykinin (0.8 microM) were used to induce release of t-PA and vWF. The guanylate cyclase activators sodium nitroprusside and atrial natriuretic factor reduced the induced release of t-PA and vWF. Release was not affected by inhibiting nitric oxide production with NG-nitro-L-arginine. The effects of nitroprusside and atrial natriuretic factor could not be reproduced by infusion of 8-bromo-cGMP. The adenylate cyclase activator forskolin had no effect on bradykinin-induced release of t-PA and vWF, reduced PAF-induced t-PA release, but potentiated PAF-induced vWF release. These modulatory effects were only partially mimicked by infusion of 8-bromo-cAMP. None of the compounds tested was able to induce the release of t-PA or of vWF in the absence of stimulation by bradykinin or platelet-activating factor. Cyclic nucleotides can thus modulate, but not induce, the acute release of t-PA and vWF from perfused rat hindlegs.

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Adenylyl Cyclase Inhibitors
  • Adenylyl Cyclases / metabolism
  • Animals
  • Atrial Natriuretic Factor / pharmacology
  • Bradykinin / pharmacology
  • Colforsin / pharmacology
  • Cyclic AMP / physiology*
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Cyclic GMP / physiology*
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / metabolism
  • Guanylate Cyclase / antagonists & inhibitors
  • Guanylate Cyclase / metabolism
  • Male
  • Nitroprusside / pharmacology
  • Platelet Activating Factor / pharmacology
  • Rats
  • Rats, Wistar
  • Secretory Rate / drug effects
  • Tissue Plasminogen Activator / metabolism*
  • von Willebrand Factor / metabolism*

Substances

  • Adenylyl Cyclase Inhibitors
  • Platelet Activating Factor
  • von Willebrand Factor
  • Nitroprusside
  • Colforsin
  • 8-Bromo Cyclic Adenosine Monophosphate
  • 8-bromocyclic GMP
  • Atrial Natriuretic Factor
  • Cyclic AMP
  • Tissue Plasminogen Activator
  • Adenylyl Cyclases
  • Guanylate Cyclase
  • Cyclic GMP
  • Bradykinin